• COVID-19 Update: Current Status | Last Updated October 4, 2021

    We are currently in Phase 4 of our ramp up plan, which means that core research facilities may begin allowing non-ASRC users on a limited basis, with up to 80% building occupancy allowed.

    Please review our policies for increasing on-site research activity following NYS PAUSE and check back regularly for status updates.

Featured News | Structural Biology

The ‘Awesome Power of Interdisciplinary Science’: How a CUNY ASRC Biochemist Contributed to an FDA-Approved Drug

Belzutifan is approved to treat cancers of the kidneys, central nervous system, and pancreas that do not call for immediate surgery, in patients with von Hippel-Lindau disease.

Full Story » More Features »